structure of mycotoxins, the effects of the deactivating substance, as well as the resulting metabolite(s), on the safety of target animals, the consumer and the environment must be presented.
The industry’s certificate of quality The requirements for EU registration are robust. The number of scientific publications required and the level of collabora- tion with highly trusted universities and research centres that is needed for EFSA’s approval followed by an EU authorisation has made EU registration a benchmark for product quality in Europe and internationally.
On-farm implications Potential pitfalls that farmers and feed millers could encoun- ter when applying non-EU registered mycotoxin inhibitors in- clude: •
Ineffectiveness against on-farm mycotoxins: animals are left unprotected
• Uncertainty regarding safety for animals or humans • Decreased nutritional value of the ration: non-specific
Oversight and purpose
“The purpose … is to establish a Community procedure for authorising the placing on the market and use of feed additives and to lay down rules for the supervision and la- belling of feed additives and premixtures in order to pro- vide the basis for the assurance of a high level of protec- tion of human health, animal health and welfare, environment and users’ and consumers’ interests in rela- tion to feed additives, whilst ensuring the effective func- tioning of the internal market”. Regulation (EC) 1831/2003
binders can bind toxins, nutrients and vitamins
• Nonexistent or negative return on investment due to the factors above
Without an appropriate mycotoxin risk management plan that utilises scientifically proven mycotoxin-inhibiting additives, farmers and feed millers could continue to see mycotoxins negatively impact their operations in the form of lower animal performance and impaired health status along with reduced farm profitability. Applying mycotoxin deactivators that have full EU authorisation and robust scientific backing would ensure that farmers and feed millers avoid these pitfalls.
Continued commitment to science To date, only seven additives have been successfully registered as “Substances for reduction of the contamination of feed by mycotoxins” according to the EU authorisation process—and all of them are Biomin products. Though other organisations have begun the registration process, none have successfully met EFSA’s stringent requirements at the time of writing. With a long-standing focus on mycotoxin research, Biomin has developed a dynamic R&D department with more than 100 scientists and more than 200 research partner organisations around the world, as well as its own research centres. The focus on mycotoxin research is the reason why Biomin is the only company with components authorised for the “degradation of mycotoxins”. In addition to the seven already approved additives, a recombinant enzyme that biotransforms zearalenone irreversibly into non-toxic metabolites, has been submitted for authorisation in the EU. This continued commitment to science helps ensure that farmers and feed millers have the tools they need to successfully counter the negative effects of mycotoxins.
▶ MYCOTOXINS | NOVEMBER 2021 21
Thanks to strong scientific R&D, Biomin holds a world-class position in mycotoxin mitigation.
PHOTO: BIOMIN
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80
